Correlation Between Pfizer and COMCAST
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and COMCAST PORATION, you can compare the effects of market volatilities on Pfizer and COMCAST and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of COMCAST. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and COMCAST.
Diversification Opportunities for Pfizer and COMCAST
Modest diversification
The 3 months correlation between Pfizer and COMCAST is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and COMCAST PORATION in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COMCAST PORATION and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with COMCAST. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COMCAST PORATION has no effect on the direction of Pfizer i.e., Pfizer and COMCAST go up and down completely randomly.
Pair Corralation between Pfizer and COMCAST
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the COMCAST. In addition to that, Pfizer is 1.37 times more volatile than COMCAST PORATION. It trades about -0.06 of its total potential returns per unit of risk. COMCAST PORATION is currently generating about 0.05 per unit of volatility. If you would invest 7,752 in COMCAST PORATION on September 12, 2024 and sell it today you would earn a total of 84.00 from holding COMCAST PORATION or generate 1.08% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.45% |
Values | Daily Returns |
Pfizer Inc vs. COMCAST PORATION
Performance |
Timeline |
Pfizer Inc |
COMCAST PORATION |
Pfizer and COMCAST Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and COMCAST
The main advantage of trading using opposite Pfizer and COMCAST positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, COMCAST can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COMCAST will offset losses from the drop in COMCAST's long position.Pfizer vs. Victory Integrity Smallmid Cap | Pfizer vs. Hilton Worldwide Holdings | Pfizer vs. NVIDIA | Pfizer vs. JPMorgan Chase Co |
COMCAST vs. AEP TEX INC | COMCAST vs. US BANK NATIONAL | COMCAST vs. Applied Blockchain | COMCAST vs. BigBearai Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |